Opioid REMS-Compliant Accredited CE Activities Reported to ACCME —2021 Update

The ACCME has released a new data report demonstrating the scope of continuing education (CE) activities that are compliant with the US Food and Drug Administration’s (FDA) Risk Evaluation and Mitigation Strategies (REMS) related to opioid analgesics. The report reflects data available as of May 15, 2021.